文献速递间质性肺疾病

慢性过敏性肺炎系统性暴露评估工具的构建

A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity Pneumonitis.
PubMed 文献 · Chest · 2020-01-17

本研究通过系统文献综述和国际德尔菲专家共识,确定了疑似慢性过敏性肺炎(CHP)患者应询问的18个暴露条目,并基于此开发了CHP暴露评估工具。该工具经认知访谈修订,旨在标准化暴露史采集,但临床效用可能受地域暴露模式差异影响,尚需进一步验证。

要点

  • 德尔菲共识确定了18个疑似CHP患者应询问的暴露条目。
  • 暴露评估工具基于文献综述和专家共识系统构建。
  • 工具经认知访谈修订,提升可读性和可用性。

核心结论

  • 德尔菲调查确定了ILD专家认为对所有疑似CHP患者重要的询问条目,为系统性CHP暴露评估工具提供了基础。
  • 该暴露评估工具的临床效用可能受不同地区暴露模式的影响,需要持续研究进行临床验证。

研究设计与样本

  • 通过系统文献综述生成潜在致病暴露列表,并应用德尔菲法对国际ILD专家小组进行两轮调查。
  • 共识阈值设定为80%同意,且中位数≤2、四分位距=0(5点Likert量表)。
  • 两轮调查中40位专家有36位参与。

主要发现

  • 专家就18个暴露条目达成共识,应询问每位疑似CHP患者。
  • 主题包括CHP诱发暴露、影响暴露相关性的特征以及相关暴露的量化。
  • 基于文献综述和德尔菲结果推导出CHP暴露评估工具,并通过认知访谈由ILD患者修订以提高可读性和可用性。

关键数值与推荐

  • 共识阈值:80%同意,中位数≤2,四分位距=0(5点Likert量表:1强烈同意至5强烈不同意)。
  • 18个暴露条目需询问每位疑似CHP患者。

临床怎么用

  • 临床医生可使用该工具系统采集疑似CHP患者的暴露史,减少个体间差异。
  • 需考虑当地暴露模式的差异对工具效用的影响。

局限性

  • 工具的临床效用可能受不同局部暴露 prevalence 模式的影响。
  • 需要进行持续研究以临床验证这些条目,并考虑其在地理多样性环境中的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic hypersensitivity pneumonitis (CHP) is an immune-mediated interstitial lung disease (ILD) caused by inhalational exposure to environmental antigens, resulting in parenchymal fibrosis. By definition, a diagnosis of CHP assumes a history of antigen exposure, but only half of all patients eventually diagnosed with CHP will have a causative antigen identified. Individual clinician variation in eliciting a history of antigen exposure may affect the frequency and confidence of CHP diagnosis. METHODS: A list of potential causative exposures were derived from a systematic review of the literature. A Delphi method was applied to an international panel of ILD experts to obtain consensus regarding technique for the elicitation of exposure to antigens relevant to a diagnosis of CHP. The consensus threshold was set at 80% agreement, and median ≤ 2, interquartile range = 0 on a 5-point Likert scale (1, strongly agree; 2, tend to agree; 3, neither agree nor disagree; 4, disagree; 5, strongly disagree). RESULTS: In two rounds, 36/40 experts participated. Experts agreed on 18 exposure items to ask every patient with suspected CHP. Themes included CHP inducing exposures, features that contribute to an exposure's relevance, and quantification of a relevant exposure. Based on the results from the literature review and Delphi process, a CHP exposure assessment instrument was derived. Using cognitive interviews, the instrument was revised by patients with ILD for readability and usability. CONCLUSIONS: This Delphi survey provides items that ILD experts agree are important to ask in all patients presenting with suspected CHP and provides basis for a systematically derived CHP exposure assessment instrument. Clinical utility of this exposure assessment instrument may be affected by different local prevalence patterns of exposures. Ongoing research is required to clinically validate these items and consider their impact in more geographically diverse settings.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Barnes H, Morisset J, Molyneaux P, et al. A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity Pneumonitis. Chest. 2020. PMID: 31958445. doi:10.1016/j.chest.2019.12.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。